Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxycycline and the Modulation of Host Immunopathology in Human Pulmonary Tuberculosis: A Pilot Study

NCT02774993 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT02774993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxycycline and the Modulation of Host Immunopathology in Human Pulmonary Tuberculosis: A Pilot Study
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
June 30, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis